Heart Failure: An Underappreciated Complication of Diabetes. A Consensus Report of the of the ADA

PDF Preview

Heart failure (HF) has been recognized as a common complication of diabetes, with a prevalence of up to 22% in individuals with diabetes and increasing inci- dence rates. Data also suggest that HF may develop in individuals with diabetes even in the absence of hypertension, coronary heart disease, or valvular heart disease and, as such, represents a major cardiovascular complication in this vul- nerable population; HF may also be the first presentation of cardiovascular dis- ease in many individuals with diabetes.

Clinical Management of Stable Coronary Artery Disease (CAD) in Patients with T2D

Listen to members of the writing group for the new AHA statement on the clinical management of stable coronary artery disease in patients with T2D. The statement provides a comprehensive summary of effective, patient-centered management of CAD in patients with T2D, with emphasis on the emerging evidence.

Dr. Suzanne Arnold, Chair, and fellow writing group members, Dr. Prakash Deedwania and Dr. Mikhail Kosiborod will review highlights from the statement, including recent clinical trials which uncovered several new drugs that not only reduce glucose, but also improve cardiovascular and renal outcomes (Clinical Management of Stable Coronary Artery Disease in Patients with T2D Mellitus – AHA Scientific Statement).

 

Play the podcast in Apple Podcasts.

podcast player graphic

2020 Episode 6 – Clinical Management of Stable Coronary Artery Disease in Patients with T2D

Download the 2020 Episode 6 Transcript.

Mikhail Kosiborod, MD is a Cardiologist, Director of Cardiometabolic Research and Co-Director of the Haverty Cardiometabolic Center of Excellence at Saint Luke’s Mid America Heart Institute, and Professor of Medicine at the University of Missouri-Kansas City. Dr. Kosiborod is an internationally recognized expert in the fields of diabetes and cardiovascular disease, cardiometabolic and cardiorenal syndromes as well as quality of care and outcomes. He has authored and co-authored over 220 peer reviewed publications, including scientific statements and position documents. He is involved in the leadership of multiple clinical trials and multi-center registries and is currently the principal investigator of several investigator-initiated, multicenter trials in diabetes and CVD.

 

Mikhail Kosiborod

Prakash Deedwania, MD, FACC, FAHA, FESC is one of the most recognizable figures in the fields of diabetes, hypertension, heart failure, lipid disorders, ischemic heart disease, rhythm disorders and preventive cardiology where he has authored numerous landmark clinical trials and several clinical practice guidelines. He is a respected leader of several national and international medical societies, having held various positions at the AHA, the American College of Cardiology and the National Health Lung & Blood Institute. He has published over a thousand medical manuscripts, and is on the editorial board of the top medical journals including the Journal of the American College of Cardiology, American Journal of Cardiology, Clinical Cardiology, among many others.

Prakash Deedwania

Suzanne V. Arnold, MD, MHA is an Associate Professor of Medicine at the University of Missouri-Kansas City and a cardiologist at Saint Luke’s Mid America Heart Institute. She also completed a cardiovascular outcomes research fellowship through the AHA. Her research centers on the long-term outcomes of patients with CVD, with a particular focus on patients’ quality of life—how to best assess it, what factors influence it and how to improve it. She was the recipient of several research awards, including the Burton Sobel Award for Excellence in Cardiovascular Research at Washington University in St. Louis and the AHA Young Investigator Award.

Suzanne V. Arnold

Heart failure management in Patients with T2D

Listen to Dr. Nancy Albert, Clinical Nurse Specialist and lead researcher in heart failure and Dr. Mikhail Kosiborod, Cardiologist and expert in the fields of diabetes, CVD, cardiometabolic and cardiorenal syndromes and quality care and outcomes discuss heart failure management in patients with T2D and CVD.

Play the podcast in Apple Podcasts.

podcast player graphic

2020 Episode 4 – Heart Failure Management in Patients with T2D and CVD

Download the 2020 Episode 4 Transcript.

Dr. Nancy M. Albert is Associate Chief Nursing Officer—Nursing Research and Innovation, Cleveland Clinic health system and a Clinical Nurse Specialist in heart failure—Kaufman Center for Heart Failure, Heart, Vascular and Thoracic Institute, Cleveland Clinic. Dr. Albert is a leader, Research Scientist, advanced Practice Nurse in a heart failure clinic, Consultant and Educator. She has 340 peer reviewed health care journal publications, over 18 book chapters and she is editor of 2016 book, Building and Sustaining a Hospital-Based Nursing Research Program. Dr. Albert volunteers for many health care organizations and presents locally, nationally and internationally on cardiovascular (heart failure), research and innovation themes.

Dr. Nancy M. Albert

Dr. Mikhail Kosiborod is a Cardiologist, Director of Cardiometabolic Research and Co-Director of the Haverty Cardiometabolic Center of Excellence at Saint Luke’s Mid America Heart Institute, and Professor of Medicine at the University of Missouri-Kansas City. Dr. Kosiborod is an internationally recognized expert in the fields of diabetes and CVD, cardiometabolic and cardiorenal syndromes as well as quality of care and outcomes. He has authored and co-authored over 220 peer reviewed publications, including scientific statements and position documents. He is involved in the leadership of multiple clinical trials and multi-center registries and is currently the principal investigator of several investigator-initiated, multicenter trials in diabetes and CVD.

Dr. Mikhail Kosiborod

Diabetes and Heart Failure

Identifying and implementing optimal treatment strategies for patients living with diabetes and heart failure is critical to improving outcomes for this population. Shannon Dunlay, MD, MS discusses managing patients with diabetes who are at risk for heart failure or those that have heart failure. This podcast is based on the new scientific statement from the American Heart Association and the Heart Failure Society of America.*

* Type 2 Diabetes Mellitus and Heart Failure

Play the podcast in Apple Podcasts.

podcast player graphic

Episode 6 – Diabetes and Heart Failure

Download the Episode 6 Transcript.

Shannon Dunlay, MD, MS is a is an Advanced Heart Failure Cardiologist and Associate Professor of Medicine and Health Services Research at the Mayo Clinic in Rochester, Minnesota. Her research focuses on examining factors that impact health care utilization and outcomes in patients with heart failure. Clinically, she cares for patients with advanced heart failure, including those that require mechanical circulatory support and cardiac transplantation. She has been an active member of the American Heart Association where she serves on several committees and is an Associate Editor at Circulation: Cardiovascular Quality and Outcomes.

Shannon Dunlay, MD, MS

Shannon Dunlay, MD, MS